Lingohr & Partner Asset Management GmbH Sells 3,368 Shares of Express Scripts Holding Co (ESRX)

Lingohr & Partner Asset Management GmbH decreased its position in shares of Express Scripts Holding Co (NASDAQ:ESRX) by 15.0% in the 3rd quarter, HoldingsChannel reports. The fund owned 19,158 shares of the company’s stock after selling 3,368 shares during the period. Express Scripts makes up about 1.2% of Lingohr & Partner Asset Management GmbH’s holdings, making the stock its 14th biggest holding. Lingohr & Partner Asset Management GmbH’s holdings in Express Scripts were worth $1,820,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in ESRX. Aperio Group LLC boosted its position in shares of Express Scripts by 4.4% during the third quarter. Aperio Group LLC now owns 576,650 shares of the company’s stock valued at $54,788,000 after buying an additional 24,131 shares during the last quarter. Foundry Partners LLC boosted its position in shares of Express Scripts by 18.7% during the third quarter. Foundry Partners LLC now owns 140,660 shares of the company’s stock valued at $13,364,000 after buying an additional 22,145 shares during the last quarter. Kassirer Asset Management Corp boosted its position in shares of Express Scripts by 1,440.2% during the third quarter. Kassirer Asset Management Corp now owns 42,000 shares of the company’s stock valued at $3,990,000 after buying an additional 39,273 shares during the last quarter. Nisa Investment Advisors LLC boosted its position in shares of Express Scripts by 15.4% during the third quarter. Nisa Investment Advisors LLC now owns 243,045 shares of the company’s stock valued at $23,092,000 after buying an additional 32,407 shares during the last quarter. Finally, Andra AP fonden boosted its position in shares of Express Scripts by 6.2% during the third quarter. Andra AP fonden now owns 151,000 shares of the company’s stock valued at $14,347,000 after buying an additional 8,800 shares during the last quarter. Hedge funds and other institutional investors own 84.73% of the company’s stock.

In other news, insider Christine Houston sold 12,898 shares of the company’s stock in a transaction on Friday, August 10th. The stock was sold at an average price of $85.00, for a total transaction of $1,096,330.00. Following the transaction, the insider now owns 110,908 shares of the company’s stock, valued at approximately $9,427,180. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.79% of the stock is owned by corporate insiders.

Shares of NASDAQ ESRX traded up $0.06 during trading on Thursday, reaching $95.83. 126,370 shares of the stock traded hands, compared to its average volume of 4,291,423. Express Scripts Holding Co has a 52-week low of $55.80 and a 52-week high of $97.22. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.71 and a quick ratio of 0.59. The stock has a market capitalization of $53.41 billion, a PE ratio of 13.50, a P/E/G ratio of 1.20 and a beta of 1.01.

Express Scripts (NASDAQ:ESRX) last issued its quarterly earnings results on Wednesday, August 1st. The company reported $2.22 EPS for the quarter, beating analysts’ consensus estimates of $2.20 by $0.02. Express Scripts had a return on equity of 25.49% and a net margin of 4.65%. The firm had revenue of $25.64 billion for the quarter, compared to analysts’ expectations of $25.43 billion. During the same quarter in the prior year, the firm earned $1.73 EPS. The business’s revenue for the quarter was up 1.2% compared to the same quarter last year. As a group, equities analysts expect that Express Scripts Holding Co will post 9.07 EPS for the current fiscal year.

Several research analysts have weighed in on ESRX shares. BidaskClub cut Express Scripts from a “buy” rating to a “hold” rating in a research report on Tuesday, July 10th. Credit Suisse Group cut Express Scripts from an “outperform” rating to a “neutral” rating and boosted their price objective for the stock from $90.00 to $96.50 in a research report on Tuesday, September 18th. Zacks Investment Research raised Express Scripts from a “strong sell” rating to a “hold” rating in a research report on Tuesday, June 26th. Royal Bank of Canada boosted their price objective on Express Scripts to $94.00 and gave the stock an “outperform” rating in a research report on Monday, August 27th. Finally, William Blair raised Express Scripts from a “market perform” rating to an “outperform” rating in a research report on Wednesday, August 1st. Two research analysts have rated the stock with a sell rating, twelve have issued a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $86.36.

Express Scripts Company Profile

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Further Reading: What are trading strategies for the 52-week high/low?

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply